Catamaran Corp. (NASDAQ: CTRX) (TSX: CCT) said it has completed the acquisition of Restat, LLC for a purchase price of USD409.5m in cash.
The purchase price was funded from Catamaran´s existing cash balance and USD350m in borrowings under its revolving credit facility.
Restat provides prescription claim processing and PBM services. It is based in Milwaukee, Wisconsin, where its operations will remain.
Catamaran, one of the industry´s fastest-growing pharmacy benefits manager, helps organizations and the communities they serve take control of prescription drug costs. It is headquartered in Schaumburg, Illinois with multiple locations in the US and Canada. For more information, visit CatamaranRx.com.